Kurt Rasmussen

Affiliations: 
Eli Lilly, Indianapolis, IN, United States 
Google:
"Kurt Rasmussen"
Mean distance: 14.85 (cluster 19)
 
SNBCP

Children

Sign in to add trainee
Matthew A. Seager post-doc 2002-2005
Gavin Stewart Dawe research scientist 2000-2001 Eli Lilly
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Marek GJ, Cunningham KA, Rasmussen K. (2019) Translating Pharmacology into Therapeutics to Fight the Opioid Crisis. The Journal of Pharmacology and Experimental Therapeutics. 371: 394-395
Coussens NP, Sittampalam GS, Jonson SG, et al. (2019) The Opioid Crisis and the Future of Addiction and Pain Therapeutics. The Journal of Pharmacology and Experimental Therapeutics
Balcer OM, Seager MA, Gleason SD, et al. (2018) Evaluation of 5-HT receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice. Behavioural Brain Research. 360: 270-278
Rasmussen K, White DA, Acri JB. (2018) NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Pedersen AHM, Rasmussen K, Grytnes R, et al. (2018) Collaboration and patient safety at an emergency department - a qualitative case study. Journal of Health Organization and Management. 32: 25-38
Kjellberg J, Wolf RT, Kruse M, et al. (2017) Costs associated with adverse events among acute patients. Bmc Health Services Research. 17: 651
Hufgard JR, Williams MT, Skelton MR, et al. (2017) Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a. Psychopharmacology
Witkin JM, Mitchell S, Wafford K, et al. (2017) Comparative Effects of LY3020371, a Potent and Selective mGlu2/3 Receptor Antagonist, and Ketamine, a Non-Competitive NMDA Receptor Antagonist, in Rodents: Evidence Supporting Use for the Treatment of Depression. The Journal of Pharmacology and Experimental Therapeutics
Kato AS, Burris KD, Gardinier KM, et al. (2016) Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism. Nature Medicine
Biering K, Lander F, Rasmussen K. (2016) Work injuries among migrant workers in Denmark. Occupational and Environmental Medicine
See more...